Mass General Research Study: Effectiveness and safety of fluoxetine for the treatment of depression in adults with Down syndrome

Does your adult child with Down syndrome have symptoms of
depression?
​
The Massachusetts General Hospital at the Lurie Center is currently
recruiting for a new research study that will evaluate the effectiveness
and safety of the drug fluoxetine for the treatment of depression in
adults with Down syndrome.

Participants must be:

• 18 to 45 years of age
• diagnosed with Down syndrome
• have symptoms of depression

For more information, please contact Dr. Robyn Thom’s research staff at:
(781) 860-1711 or LurieCenterResearch@partners.org